Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL7P14 is a processed pseudogene related to the ribosomal protein L7 (RPL7) gene in humans. Unlike the functional RPL7 gene, which encodes a component of the large 60S ribosomal subunit and is involved in translation, RPL7P14 does not code for any functional protein and is not considered a therapeutic target[3][4][5]. Pseudogenes like RPL7P14 are generally derived from functional ribosomal protein genes through genomic duplication or retrotransposition, and while the sequence similarity exists, their biological role is usually limited or absent[4][7]. There is currently no information indicating any drug interactions, biomarker utility, safety concerns, or direct involvement in disease for this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L7 pseudogene 14 (RPL7P14).